From Dubai to Nashik: Robotic Surgery Helps 62-Year-Old Prostate Cancer Patient Return Home Within Two Weeks

HCG Manavata Cancer Centre Successfully Treats International Prostate Cancer Patient with Robotic Surgery

NASHIK, July 7: In a remarkable journey spanning continents and medical specialties, HCG Manavata Cancer Centre (HCGMCC), Nashik, successfully treated 62-year-old Mr Bosco Daniel, a Dubai-based hotelier, for prostate cancer using advanced robotic-assisted surgery.

What began as a sudden cardiac emergency in India became a life-changing moment when routine investigations during hospitalization revealed an incidental diagnosis of early-stage prostate cancer. After evaluating treatment options across several leading metropolitan hospitals, Bosco chose HCGMCC in Nashik for his cancer treatment.

Cancer Diagnosis During Cardiac Treatment

Bosco had travelled to India for an angioplasty to address his cardiac condition. However, subsequent medical evaluations uncovered prostate cancer, presenting doctors with a complex clinical challenge.

Following angioplasty, surgery is generally deferred for at least six months because of the increased risk of stent thrombosis. To safely manage the cancer during this period, Prof Dr Raj Nagarkar and his multidisciplinary team administered hormone therapy, effectively controlling the disease while allowing Bosco's heart to recover.

"Bosco's case required careful coordination between cardiac and cancer care. Regarding his health, there were two challenges viz. how to address his prostate cancer without compromising his heart health. We used hormone therapy for 3 to 6 months, which kept the cancer in check while his cardiac condition stabilised. Once the safe window arrived, we proceeded with robotic assisted surgery. This is the importance of individualized treatment planning, where every decision is made in the patient's best interest rather than following a one-size-fits-all approach. Bosco recovered exceptionally well and returned to his country within a fortnight," said Prof Dr Raj Nagarkar, Chief of Surgical Oncology & Robotic Services and Managing Director, KIMS Manavata Hospitals, HCG Manavata Cancer Centre and Six Sigma, Nashik.

Rapid Recovery Through Robotic-Assisted Surgery

The minimally invasive robotic-assisted procedure was completed successfully, enabling Bosco to recover quickly. He was able to walk and resume basic activities within two days, was discharged from the hospital after three days, and returned to Dubai within two weeks.

Following removal of the urinary catheter one week later, he regained complete bladder control. His final histopathology report also confirmed that no additional treatment, including radiation therapy, was required.

Robotic Surgery Improves Outcomes for Prostate Cancer Patients

"One of the biggest concerns among men diagnosed with prostate cancer is the fear of losing urinary control after surgery. Thanks to advances in robotic assisted surgery and growing surgical expertise, these risks have reduced significantly. Robotic surgery offers unmatched precision, enabling better preservation of vital nerves and structures, resulting in faster recovery, minimal pain, shorter hospital stay and excellent functional outcomes. In Mr Bosco's case, he regained complete bladder control soon after catheter removal and was able to return to his normal life without requiring any additional treatment. Cases like these reinforce why robotic surgery has become one of the preferred treatment options for appropriately selected patients with localized prostate cancer," Dr Nagarkar added.

Continuity of Care Beyond Borders

Now back in Dubai, Bosco continues to receive follow-up care through regular tele-consultations and virtual appointments with Dr Nagarkar and his team. The ongoing support highlights HCGMCC's commitment to delivering seamless continuity of care for international patients even after they return home.

About HCG Manavata Cancer Centre

HCG Manavata Cancer Centre, Nashik, is part of the HCG network of cancer care hospitals and offers comprehensive oncology services, including robotic-assisted surgery, medical oncology, radiation oncology, diagnostics and multidisciplinary cancer care.

(Inputs from Press Release)